Drug Development and Discovery features Dr. Peter Vanderslice

The May issue of Drug Development and Discovery featured research by Dr. Peter Vanderslice, Director of Biology in the THI Molecular Cardiology Research Laboratory. His discovery is now in testing to help improve the effectiveness of vaccines and cancer.

IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies